{"id":"mk-0653-ezetimibe","safety":{"commonSideEffects":[{"rate":"1-5%","effect":"Musculoskeletal pain"},{"rate":"1-5%","effect":"Diarrhea"},{"rate":"1-5%","effect":"Flatulence"}]},"_chembl":{"chemblId":"CHEMBL1138","moleculeType":"Small molecule","molecularWeight":"409.43"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Ezetimibe works by binding to the Niemann-Pick C1-Like 1 (NPC1L1) protein on the surface of intestinal cells, preventing the absorption of cholesterol from the diet. This leads to a decrease in the amount of cholesterol available for transport to the liver, resulting in lower levels of cholesterol in the blood.","oneSentence":"Ezetimibe inhibits the absorption of cholesterol in the small intestine.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:50:02.241Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hyperlipidemia"},{"name":"Homozygous familial hypercholesterolemia"}]},"trialDetails":[{"nctId":"NCT00092560","phase":"PHASE3","title":"Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2002-12","conditions":"Hypercholesterolemia, Hypertriglyceridemia","enrollment":587},{"nctId":"NCT00651963","phase":"PHASE4","title":"Open Label Study Evaluating The Use Of Combination Therapy Of Ezetimibe And Statins In Patients With Dyslipidemia In Colombia (0653-141)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-09","conditions":"Lipid Metabolism Disorder","enrollment":80},{"nctId":"NCT00653276","phase":"PHASE1","title":"MD Ezetimibe Cyclosporine Interaction (0653-057)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-11","conditions":"Cholesterol","enrollment":13},{"nctId":"NCT00092586","phase":"PHASE3","title":"Study of an Approved Drug With a Statin (a Medication That Lowers Cholesterol Levels) as Compared to Statin Therapy Alone in Patients With High Cholesterol (0653-040)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2002-09","conditions":"Hypercholesterolemia","enrollment":2904},{"nctId":"NCT00652847","phase":"PHASE4","title":"Randomized Parallel Group Trial Of The Efficacy And Safety Of Ezetimibe With A Statin Versus Statin Dose Doubling In Patients With Persistent Primary Hypercholesterolemia (0653-152)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-05","conditions":"Hypercholesterolemia","enrollment":1140},{"nctId":"NCT00652717","phase":"PHASE4","title":"Study To Assess The Efficacy Of A Cholesterol Lowering Drug On Top Of Statins In Patients After Myocardial Infarction (MI)(0653A-150)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-02-01","conditions":"Cardiovascular Disorder","enrollment":280},{"nctId":"NCT00551876","phase":"PHASE3","title":"Study Evaluating the Efficacy and Safety of Simvastatin Alone Compared With Simvastatin Plus Ezetimibe in Type 2 Diabetic Patients (0653-021)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2001-12","conditions":"Diabetes Mellitus, Type 2","enrollment":214},{"nctId":"NCT00551447","phase":"PHASE3","title":"A Study Comparing Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Patients at Risk for Heart Disease (0653-023)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2002-01","conditions":"Coronary Disease","enrollment":616},{"nctId":"NCT00457275","phase":"PHASE3","title":"Observational Study to Evaluate LDL-C Lowering Effect of Ezetimibe (0653-070)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-04","conditions":"Hypercholesterolemia","enrollment":440},{"nctId":"NCT00092820","phase":"PHASE3","title":"Sitosterolemia Extension Study (0653-004)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2001-02-12","conditions":"Lipid Metabolism, Inborn Errors, Heart Disease","enrollment":58},{"nctId":"NCT00092638","phase":"PHASE3","title":"An Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-804)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-05","conditions":"Hypercholesterolemia, Coronary Disease","enrollment":450},{"nctId":"NCT00092625","phase":"PHASE3","title":"Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-803)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-03","conditions":"Hypercholesterolemia, Coronary Disease","enrollment":442},{"nctId":"NCT00092716","phase":"PHASE3","title":"Comparing an Investigational Medication Versus an Approved Medication in Reducing Cholesterol Levels (0653-025)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2002-05","conditions":"Hypercholesterolemia","enrollment":655},{"nctId":"NCT00157911","phase":"PHASE3","title":"A Study to Evaluate Ezetimibe in Korean Patients With Primary Hypercholesterolemia (0653-042)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2002-12","conditions":"Hypercholerolemia","enrollment":136},{"nctId":"NCT00092807","phase":"PHASE3","title":"Sitosterolemia Extension Study (0653-003)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2001-02-12","conditions":"Lipid Metabolism, Inborn Errors, Heart Disease","enrollment":37},{"nctId":"NCT00652301","phase":"PHASE3","title":"A Research Study to Evaluate MK0653 (Ezetimibe) and Simvastatin, Given Together and Alone, on Intestinal Absorption of Cholesterol (0653-050)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-07","conditions":"Cholesterol","enrollment":40},{"nctId":"NCT00092898","phase":"PHASE3","title":"An Investigational Drug Study to Lower Non-Cholesterol Sterol Levels Associated With Sitosterolemia (0653-062)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-10","conditions":"Lipid Metabolism, Inborn Errors, Heart Disease","enrollment":30},{"nctId":"NCT00092612","phase":"PHASE3","title":"Co-administration Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-802)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-05","conditions":"Hypercholesterolemia, Coronary Disease","enrollment":372},{"nctId":"NCT00092833","phase":"PHASE3","title":"Investigational Drug in Patients With Hypercholesterolemia or in Patients With Sitosterolemia (0653-026)(COMPLETED)","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2002-07","conditions":"Hypercholesterolemia, Familial, Lipid Metabolism, Inborn Errors","enrollment":49},{"nctId":"NCT00092599","phase":"PHASE3","title":"Investigational Drug Study in Patients With Elevated Cholesterol and Coronary Heart Disease (0653-801)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-02","conditions":"Hypercholesterolemia, Coronary Disease","enrollment":410},{"nctId":"NCT00328523","phase":"PHASE3","title":"TWICE (Ezetimibe Together With Any Statin Cholesterol Enhancement)(0653-060)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-06","conditions":"Hypercholesterolaemia, Hyperlipidaemia","enrollment":1496},{"nctId":"NCT00092573","phase":"PHASE3","title":"Study of Ezetimibe and Fenofibrate in Patients With Mixed Hyperlipidemia (0653-036)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-04","conditions":"Hypercholesterolemia, Hypertriglyceridemia","enrollment":576},{"nctId":"NCT00101439","phase":"PHASE3","title":"A Study to Evaluate the Effects of Ezetimibe (MK-0653) on the Postprandial (Following a Meal) Lipoprotein Response in Participants With Primary Hypercholesterolemia (High Cholesterol) (MK-0653-072)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-11-10","conditions":"Hypercholesterolemia","enrollment":58},{"nctId":"NCT01611883","phase":"PHASE4","title":"A Study of the Effect of Ezetimibe on Glucose Metabolism in Type 2 Diabetics With Hypercholesterolemia (P06541)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2012-07-02","conditions":"Hypercholesterolemia","enrollment":152},{"nctId":"NCT00867165","phase":"PHASE3","title":"Pediatric Study to Evaluate the Efficacy and Safety of Ezetimibe Monotherapy in Children With Primary Hypercholesterolemia (P05522)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2009-05-21","conditions":"Primary Hypercholesterolemia","enrollment":138},{"nctId":"NCT03867110","phase":"PHASE3","title":"An Efficacy and Safety Study of Ezetimibe (MK-0653, SCH 58235) in Addition to Atorvastatin Compared to Placebo in Participants With Primary Hypercholesterolemia (MK-0653-013)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2000-03-06","conditions":"Hypercholesterolemia","enrollment":628},{"nctId":"NCT03882892","phase":"PHASE3","title":"Long-Term Safety and Tolerability of Ezetimibe (SCH 58235, MK-0653) With Atovastatin (P02154, MK-0653-017)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2001-02-02","conditions":"Hypercholesterolemia","enrollment":400},{"nctId":"NCT00395473","phase":"PHASE3","title":"Ezetimibe Added to Statin Therapy (EASY) Study (0653-087)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-03","conditions":"Hypercholesterolemia","enrollment":141},{"nctId":"NCT03884452","phase":"PHASE3","title":"Ezetimibe (SCH 58235) Taken With Either Atorvastatin or Simvastatin in Participants With Familial Hypercholesterolemia (MK-0653-018)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2000-05-03","conditions":"Familial Hypercholesterolemia","enrollment":50},{"nctId":"NCT03867318","phase":"PHASE3","title":"Efficacy and Safety Study of Ezetimibe (SCH 58235, MK-0653) in Addition to Atorvastatin in Participants With Coronary Heart Disease or Multiple Cardiovascular Risk Factors (P00693/MK-0653-030)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2000-04-24","conditions":"Hypercholesterolemia","enrollment":621},{"nctId":"NCT00652444","phase":"PHASE4","title":"Effect Of Ezetimibe Coadministration With Simvastatin In A Middle Eastern Population: A Prospective, Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial (0653-151)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-09","conditions":"Hypercholesterolemia","enrollment":120},{"nctId":"NCT03885921","phase":"PHASE3","title":"Safety and Tolerability Study of Ezetimibe (SCH 058235/MK-0653) Plus Atorvastatin or Simvastatin in Homozygous Familial Hypercholesterolemia (P01417/MK-0653-019)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2000-10-25","conditions":"Hypercholesterolemia","enrollment":44},{"nctId":"NCT03882996","phase":"PHASE3","title":"A Long-term Safety and Tolerability Study of Ezetimibe Plus Atorvastatin in Participants With Coronary Heart Disease, Multiple Risk Factors, or Hypercholesterolemia Not Controlled by Atorvastatin (P01418/MK-0653-032)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2000-10-06","conditions":"Hypercholesterolemia","enrollment":432},{"nctId":"NCT00753883","phase":"PHASE4","title":"Ezetrol Post-Marketing Study","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2006-07","conditions":"Hyperlipidemia","enrollment":40}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":4890,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"MK-0653, ezetimibe","genericName":"MK-0653, ezetimibe","companyName":"Organon and Co","companyId":"organon-and-co","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ezetimibe inhibits the absorption of cholesterol in the small intestine. Used for Hyperlipidemia, Homozygous familial hypercholesterolemia.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}